- It was a modestly risk off day for markets yesterday, with European and US indices finishing the day marginally in the red, as investors took some profits following a four-week rally.
- Prior to holding its R&D day, Novartis this morning noted that having now completed its transformation into a “pure-play” innovative medicines company, it was upgrading its mid-term revenue growth guidance to 5% CAGR between 2022 and 2027.
- US treasury prices were broadly flat on the day following a successful auction on Monday with the 10-year yield remaining close to a two -month low.
Overview
Investment Solutions
Pension Solutions
SDIO
Application Forms – Intermediaries
Creating impact for your clients, their financial goals, and their future
Overview
Focused on your organisation, funding its growth, and unlocking its full potential
Debt Capital Markets
Probate Services
Dedicated to institutional wealth, stakeholder value, and a sustainable future
Overview
Investment Services
Stewardship
Supportive of you, your custodial vision, and your philanthropic goals
X